Desk›Healthcare› Brooks Laboratories Ltd
Brooks Laboratories Ltd
BSE 533543 · NSE BROOKS · ISIN INE650L01011 · Group T · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹66.54
+4.99%
BSE close, 28 August 2026
₹196.01 cr
2.9 cr shares · Micro cap
₹92.86 cr
as published
42.9× · 2.79×
EPS ₹1.55 · BV ₹23.85
85.74 / 5.81
₹ cr, as filed
22
4 selected · 18%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -59.1% |
|---|---|
| Against 52-week low | +80.3% |
| Day change | +4.99% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹1.55 |
|---|---|
| Price / earnings | 42.93× |
| Price / book | 2.79× |
| Book value — derived, price ÷ P/B | ₹23.85 |
| Return on equity | 6.51% |
| Operating margin | 8.88% |
| Net margin | 6.18% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 6.50%
- ROE as published
- 6.51%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 22.96 | 1.42 | 0.48 | 8.88% | 6.18% |
| Mar-26 · Q | 20.21 | 0.61 | 0.21 | 5.52% | 3.04% |
| FY25-26 | 85.74 | 5.81 | 1.97 | 9.60% | 6.77% |
Quarter on quarter
- Revenue, quarter on quarter
- +13.6%
- Net profit, quarter on quarter
- +132.8%
- Operating margin, quarter on quarter
- +336 bps
Disclosure profile 22 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| KMP | 1 |
| Results | 1 |
| Scheme of Arrangement | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 4 |
| Newspaper Publication | 4 |
| Annual Report | 2 |
| General | 2 |
| Board Meeting | 1 |
| Book Closure | 1 |
| Clarification | 1 |
| Compliance Certificate | 1 |
| Outcome | 1 |
| Trading Window | 1 |
| Procedural sub-total | 18 |
| Total | 22 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 98 trading days
22 filings · 4 selected · busiest 2026-08-12 and 2026-08-13
Filing rhythm · the twelve most recent
2026-08-212026-10-14
SelectedProcedural
Filings
22 in the window · 6 earlier on record
-
14 October 2026 ·
Scheme of Arrangement
Outcome of Board Meeting under Regulation 30 of LODR for the Scheme of Arrangement
Company Update / Scheme of Arrangement View filing →
-
14 October 2026 ·
533543 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (As Amended From Time To Time)
Outcome of Board Meeting held on Wednesday, October 14, 2026
Others / Outcome without intimation View filing →
-
13 October 2026 ·
Reply To Clarification Sought Vide Email Dated 12Th October 2026 With Reference To Price Movement.
please find attached for clarification for movement in price
Company Update / General View filing →
-
12 October 2026 ·
Clarification sought from Brooks Laboratories Ltd
The Exchange has sought clarification from Brooks Laboratories Ltd on October 12, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Company Update / Clarification
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached coverletter alongwith certificate under regulation 74(5).
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
22 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
16 September 2026 ·
Resignation of Company Secretary / Compliance Officer
Resignation of Ms. Krutika Rane as Company Secretary and Compliance Officer of the Company with effect from 9th October 2026.
Company Update / Resignation of Company Secretary / Compliance Officer View filing →
-
16 September 2026 ·
Newspaper Publication
Newspaper Publication regarding re-lodgement of transfer deed.
Company Update / Newspaper Publication View filing →
-
4 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
AGM/EGM / AGM View filing →
-
3 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 24th AGM held on Thursday, September 3, 2026.
AGM/EGM / AGM View filing →
-
21 August 2026 ·
Addendum To The Notice Of 24Th Annual General Meeting Of The Company.
Please find attached addendum to the notice of 24th Annual General Meeting.
AGM/EGM / AGM View filing →
-
21 August 2026 ·
Reg. 34 (1) Annual Report.
Addendum to the Notice of 24th Annual General Meeting of the Company.
Others / Reg. 34 (1) Annual Report View filing →
-
17 August 2026 ·
Intimation Of Record Date, E-Voting Dates And Book Closure Date
Intimation of Record date, E-Voting dates and Book Closure date.
Corp. Action / Book Closure View filing →
-
14 August 2026 ·
Newspaper Publication
Newspaper publication dated 14th August 2026 of Unaudited Financial Results for the quarter ended 30th June 2026.
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
Results - Financial Results For June 30, 2026.
Financial Results for quarter ended June 30,2026.
Result / Financial Results View filing →
-
13 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026
Outcome of Board Meeting held on Thursday, 13th August, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026 ·
Newspaper Publication
Newspaper publication regarding 24th AGM of the Company to be held on 3rd September 2026.
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Letter To The Shareholders - Annual Report For The FY 2025-26.
Letter to the Shareholders-Annual Report for the FY 2025-26
Company Update / General View filing →
-
12 August 2026 ·
Shareholder Meeting- AGM On 3Rd September 2026.
Notice of 24th Annual General Meeting of the Company to be held on 3rd September 2026 through VC/OAVM.
AGM/EGM / AGM View filing →
-
12 August 2026 ·
Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 read with Regulation 30 of SEBI Listing Regulations, we are enclosing herewith the following: 1. Notice of the AGM.2. Annual Report for the Financial Year 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
7 August 2026 ·
Newspaper Publication
Newspaper Advertisement - Intimation of 24th Annual General Meeting of the Company through VC/OAVM.
Company Update / Newspaper Publication View filing →
-
6 August 2026 ·
Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
Brooks Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve and take on record the ....
Board Meeting / Board Meeting View filing →
RSS feed for Brooks Laboratories Ltd · the 50 most recent filings